Results 111 to 120 of about 23,251 (236)
PD‐L1‐Inhibitor‐Associated Hidradenitis Suppurativa
Journal of Cutaneous Pathology, EarlyView.
Annie Jin +2 more
wiley +1 more source
OX40/OX40L modulation: A target for regulating T cells in cutaneous inflammatory disorders
Journal of the European Academy of Dermatology and Venereology, EarlyView.OX40 and OX40L are a co‐stimulatory immune checkpoint pair. Modulation of this pair impacts multiple immune phenotypes and is an attractive target for immunotherapy in dermatological disorders. Trials are underway with the majority in atopic dermatitis and currently in phase 3 trials.
Aditya K. Gupta +4 more
wiley +1 more source
Childhood alopecia areata: What treatment works best? [PDF]
, 2011 There are no validated effective treatments for alopecia areata (AA). Topical immunotherapy (squaric acid dibutylester [SADBE] and diphenylcyclopropenone [DPCP]) induces the most significant short-term hair regrowth in children with severe AA (strength ...
Haynes, James W. +2 more
core
Pediatric Dermatology, EarlyView.ABSTRACT Background Alopecia areata (AA) is an autoimmune disease affecting hair follicles that results in nonscarring hair loss. AA impacts 0.1%–0.2% of the United States population, with pediatric patients accounting for 16.0%–27.7% of all cases.
Radhika Gupta +7 more
wiley +1 more source
Alopecia areata and autoimmunity: A clinical study
Indian Journal of Dermatology, 2008 Alopecia areata (AA) frequently occur in association with other autoimmune diseases such as thyroid disorders, anemias and other skin disorders with autoimmune etiology.
Thomas Emy, Kadyan R
doaj
Оценка дерматоскопических маркеров при гнёздной алопеции [PDF]
, 2013 У хворих з різними формами захворювання розглянуто основні дерматоскопічні маркери гніздової алопеції, що мають патогенетичну основу, в залежності від стадії патологічного процесу.
Овчаренко, Ю.С. +1 more
core
Pediatric Dermatology, EarlyView.ABSTRACT Alopecia areata (AA) is an immune‐mediated hair loss disorder that can affect various demographics, including pediatric patients, and in turn, severely impact self‐esteem, peer interactions, and overall quality of life (QoL). Existing QoL tools, such as the Children's Dermatology Life Quality Index (CDLQI), address pertinent aspects of QoL ...
Shanti Mehta +3 more
wiley +1 more source
Использование препаратов метаболического действия в терапии гнёздной алопеции [PDF]
, 2010 Вивчена ефективність препарату метаболічної дії Кардонату при лікуванні хворих на гніздову алопецію. Показано позитивний вплив комплексної терапії з використанням Кардонату на клінічний перебіг дерматозу, рівень показників перекисного окислення ліпідів і
Сербина, И.М.
core
JAK inhibitors and menstrual cycle alterations: insights from a case series of 16 female patients
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Luciano Ibba +11 more
wiley +1 more source
Optimization of photobiomodulation therapy for spinal cord injury: A review
Photochemistry and Photobiology, EarlyView.Photobiomodulation (PBM) therapy in the red and near‐infrared range can significantly modulate the secondary injury response and promote the reparative and regenerative potential of neural tissue after spinal cord injury (SCI). At present, due to the nature of delivery methods, the most effective dose and irradiance at the injury site to optimize ...
Isabella K. M. Drew +3 more
wiley +1 more source